{"text": "because it can invest in at least 50 different combo trials targeting different indications even might bmy with opdivo can t compete chrs will be crushed not likely to exceed 100m in first year worse than udencya"}
{"text": "nktr stock breaks out on combination study with mrk s keytruda stocks investingnews biotech bmy"}
{"text": "bmy max pain 62 00 maturity 02 19 2021 maxpain options"}
{"text": "mrk took no risk in this it just sells keytruda to nktr i wonder why nktr wanted sfj to be involved it has plenty of capital thanks to the bmy deal why not keep all to itself"}
{"text": "buffet buying bmy abbv vz and cvx is saying stocks especially high flying growth stocks are due for a correction locking in gt 3 dividend yields in excellent and secure companies trimming aapl"}
{"text": "bmy pe 7 5x cray"}
